Literature DB >> 29312877

Diagnostic contribution of magnetic resonance imaging in an atypical presentation of motor neuron disease.

Lorenzo Ugga1, Cinzia Coppola2, Sirio Cocozza1, Dario Saracino2, Ferdinando Caranci3, Francesco Tuccillo2, Elisabetta Signoriello2, Sara Casertano2, Giuseppe Di Iorio2, Enrico Tedeschi1.   

Abstract

Motor neuron disease (MND) is a neurodegenerative disease determining progressive and relentless motor deterioration involving both upper and lower motor neurons (UMN and LMN); several variants at onset are described. Here we describe a case of MND presenting as pure spastic monoparesis in which magnetic resonance imaging (MRI) gave a substantial contribution in confirming the diagnosis and assessing the severity of UMN involvement. An isolated pyramidal syndrome, with complete absence of LMN signs, is a rare phenotype in the context of MND (less than 4% of total cases), especially if restricted to only one limb. Several other elements made this case an unusual presentation of MND: the late age of onset (8th decade), the subacute evolution of symptoms (raising the suspicion of an ischemic or inflammatory, rather than degenerative, etiology), the patient's past medical history (achalasia, erythema nodosum), the increase of inflammatory indices. Conventional MRI showed no focal lesions that could explain the clinical features; therefore, we used advanced MR sequences. Diffusion tensor imaging (DTI) evaluation evidenced bilateral impairment of corticospinal tract (CST) diffusion metrics, with clear right-left asymmetry, pointing to a neurodegenerative etiology, which clinically appeared less likely at that time. Magnetic resonance spectroscopy (MRS) showed a significant reduction of NAA/Cho + Cr ratio in the motor cortex (MC), further supporting the hypothesis of UMN degeneration. In conclusion, in this particular case of MND, whose nosographic framing has not been fully defined, advanced MRI techniques with DTI and MRS proved to be of great usefulness in confirming a diffuse UMN involvement, possibly at a more advanced stage than its clinical expression.

Entities:  

Keywords:  Motor neuron disease (MND); corticospinal tract (CST); diffusion tensor imaging (DTI); magnetic resonance spectroscopy (MRS)

Year:  2017        PMID: 29312877      PMCID: PMC5756789          DOI: 10.21037/qims.2017.10.06

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  15 in total

Review 1.  El Escorial revisited: revised criteria for the diagnosis of amyotrophic lateral sclerosis.

Authors:  B R Brooks; R G Miller; M Swash; T L Munsat
Journal:  Amyotroph Lateral Scler Other Motor Neuron Disord       Date:  2000-12

Review 2.  Errors in neuroradiology.

Authors:  Ferdinando Caranci; Enrico Tedeschi; Giuseppe Leone; Alfonso Reginelli; Gianluca Gatta; Antonio Pinto; Ettore Squillaci; Francesco Briganti; Luca Brunese
Journal:  Radiol Med       Date:  2015-07-17       Impact factor: 3.469

Review 3.  Is advanced neuroimaging for neuroradiologists? A systematic review of the scientific literature of the last decade.

Authors:  Sirio Cocozza; Camilla Russo; Giuseppe Pontillo; Lorenzo Ugga; Antonio Macera; Amedeo Cervo; Maria De Liso; Nilde Di Paolo; Maria Isabella Ginocchio; Flavio Giordano; Giuseppe Leone; Giovanni Rusconi; Arnaldo Stanzione; Francesco Briganti; Mario Quarantelli; Ferdinando Caranci; Alessandra D'Amico; Andrea Elefante; Enrico Tedeschi; Arturo Brunetti
Journal:  Neuroradiology       Date:  2016-11-08       Impact factor: 2.804

4.  Role of diffusion tensor imaging or magnetic resonance spectroscopy in the diagnosis and disability assessment of amyotrophic lateral sclerosis.

Authors:  Chanchan Liu; Rifeng Jiang; Xiyan Yi; Wenzhen Zhu; Bitao Bu
Journal:  J Neurol Sci       Date:  2014-12-06       Impact factor: 3.181

5.  White matter alterations differ in primary lateral sclerosis and amyotrophic lateral sclerosis.

Authors:  Nobue K Iwata; Justin Y Kwan; Laura E Danielian; John A Butman; Fernanda Tovar-Moll; Elham Bayat; Mary Kay Floeter
Journal:  Brain       Date:  2011-07-28       Impact factor: 13.501

6.  Phenotypic heterogeneity of amyotrophic lateral sclerosis: a population based study.

Authors:  Adriano Chiò; Andrea Calvo; Cristina Moglia; Letizia Mazzini; Gabriele Mora
Journal:  J Neurol Neurosurg Psychiatry       Date:  2011-03-14       Impact factor: 10.154

7.  The natural history of primary lateral sclerosis.

Authors:  P H Gordon; B Cheng; I B Katz; M Pinto; A P Hays; H Mitsumoto; L P Rowland
Journal:  Neurology       Date:  2006-03-14       Impact factor: 9.910

8.  Study of 962 patients indicates progressive muscular atrophy is a form of ALS.

Authors:  W-K Kim; X Liu; J Sandner; M Pasmantier; J Andrews; L P Rowland; H Mitsumoto
Journal:  Neurology       Date:  2009-11-17       Impact factor: 9.910

9.  The El Escorial criteria: strengths and weaknesses.

Authors:  Federica Agosta; Ammar Al-Chalabi; Massimo Filippi; Orla Hardiman; Ryuji Kaji; Vincent Meininger; Imaharu Nakano; Pamela Shaw; Jeremy Shefner; Leonard H van den Berg; Albert Ludolph
Journal:  Amyotroph Lateral Scler Frontotemporal Degener       Date:  2014-12-08       Impact factor: 4.092

10.  Pure Motor Monoparesis in the Leg due to a Lateral Medullary Infarction.

Authors:  Hiromasa Tsuda; Kozue Tanaka; Shuji Kishida
Journal:  Case Rep Med       Date:  2012-01-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.